Regorafenib assesment guided by metabolic imaging in refractory advanced colorectal cancer (ACRC) : REGARD-C study

Hendlisz, A; Deleporte, A; Delaunoit, T; Peeters, M; Demolin, G; Janssens , J; Holbrechts, S; Maréchal, R; Carrasco Bertrand, Javier; Van Den Eynde, M; Geboes, KP; Goeminne, JC; D'Hondt, Lionel; Paesmans, M; Vandeputte, C; Hoerner, F; Flamen, P

Regorafenib assesment guided by metabolic imaging in refractory advanced colorectal cancer (ACRC) : REGARD-C study

Hendlisz, A

;

Deleporte, A

;

Delaunoit, T

;

Peeters, M

;

Flamen, P

;et.al.

(2014) 50th annual meeting science & society - ASCO — Location: Chicago (30.May.2014)

Files

No attached file found for this publication.

Details

Authors

Hendlisz, A
Author
Deleporte, A
Author
Delaunoit, T
Author
Peeters, M
Author
D'Hondt, LionelUCLouvain
Author
Flamen, P
Author

Affiliations

UCLouvain(SLuc) Unité d'oncologie médicale
UCLouvain(SLuc) Service de psychiatrie adulte
UCLouvain(MGD) Service d'oncologie médicale
UCLouvainSSS/IREC/MONT - Pôle Mont Godinne

Citations

APA
Chicago
FWB

Hendlisz, A., Deleporte, A., Delaunoit, T., Peeters, M., Demolin, G., Janssens, J., Holbrechts, S., Maréchal, R., Carrasco Bertrand, J., Van Den Eynde, M., Geboes, K., Goeminne, J., D’Hondt, L., Paesmans, M., Vandeputte, C., Hoerner, F., & Flamen, P. (2014). Regorafenib assesment guided by metabolic imaging in refractory advanced colorectal cancer (ACRC) : REGARD-C study. 50th annual meeting science & society - ASCO, Chicago. https://hdl.handle.net/2078.5/198670